SOGROYA
SOGROYA
Approved
DIN Number
02539934
Drug Class
Human
Market Date
Nov 27, 2023
Company
HC
Novo Nordisk Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02539934
AIG Number0164861001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
H01AC07 SOMAPACITAN
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification68:28.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
SOMAPACITANActive
Strength: 5 MG / 1.5 ML
Monograph: SOMAPACITAN